Cross Atlantic sells over 1.5 million shares of Amber Road IPO

Cross Atlantic Capital Partners said Monday that it has sold over 1.5 million shares of Amber Road‘s IPO. No financial terms were disclosed. Headquartered in East Rutherford, NJ, Amber Road is a provider of global trade management solutions. It is also backed by Updata Partners, Goldman Sachs and NJTC Investment Fund.


RADNOR, Pa.–(BUSINESS WIRE)–Cross Atlantic Capital Partners announced today that it has successfully sold 1,508,953 shares in the initial public offering of Amber Road, Inc. (NYSE:AMBR).
Cross Atlantic made its first investment in Amber Road in 2002 and was the company’s largest shareholder prior to the completion of the IPO. Amber Road provides a single, on-demand platform that automates and streamlines global trade.
As a member of Amber Road’s Board of Directors, Cross Atlantic Capital Partners CEO, Donald Caldwell said, “Having been a long-time supporter of the company, we are extremely happy for their success.” He continued, “We look forward to Amber Road’s continued success in the future.”
About Cross Atlantic Capital Partners
Based in Radnor, Pa, Cross Atlantic Capital Partners (“XACP”) is one of the leading venture capital firms based in the mid-Atlantic region, with over $500 million under management. XACP invests primarily in technology companies in the United States, Ireland, and the United Kingdom. Leveraging its deep, multi-disciplined network of global contacts, and the operational experience of its investment team, the firm actively assists its entrepreneurs and portfolio companies. The XACP portfolio currently includes a diverse array of companies focusing on Enterprise Software, SaaS, IT Services, Telecommunications, Financial Services, and other innovative technologies. For more information, please visit

Take your pick!

  • Buyouts delivers exclusive news and analysis about private equity deals, fundraising, top-quartile managers and more. Get your FREE trial or subscribe now.
  • VC Journal provides exclusive news and analysis about venture capital deals, fundraising, top-quartile investors and more. Get your FREE trial or subscribe now.